Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Κ-opioid receptor - an overview | ScienceDirect Topics
Opioids - Pharmacology Flashcards | Draw it to Know it
κ-Opioid Receptor (KOP) | 7TM Antibodies
Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats† - British Journal of Anaesthesia
Kappa Receptors – Opioid Peptides
Opioid Receptors Mnemonic | Epomedicine
κ-opioid receptor - Wikipedia
Site of Opioid Action in the Human Brain: Mu and Kappa Agonists' Subjective and Cerebral Blood Flow Effects | American Journal of Psychiatry
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Kappa Receptors – Opioid Peptides
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Opioid Receptor | kappa, mu Opioid Receptor
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
6,5-Fused Ring, C2-Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience